A new trading day began on Monday, with Geron Corp (NASDAQ: GERN) stock price down -3.64% from the previous day of trading, before settling in for the closing price of $1.65. GERN’s price has ranged from $1.46 to $5.34 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 6535.01% over the past five years. Meanwhile, its annual earnings per share averaged 61.30%. With a float of $597.84 million, this company’s outstanding shares have now reached $606.39 million.
Let’s look at the performance matrix of the company that is accounted for 229 employees. In terms of profitability, gross margin is 97.97%, operating margin of -225.64%, and the pretax margin is -226.73%.
Geron Corp (GERN) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Geron Corp is 6.13%, while institutional ownership is 76.60%. The most recent insider transaction that took place on Feb 27 ’25, was worth 24,150. In this transaction EVP, Chief Legal Officer of this company bought 15,000 shares at a rate of $1.61, taking the stock ownership to the 26,682 shares. Before that another transaction happened on Feb 27 ’25, when Company’s Chairman, President and CEO bought 12,500 for $1.76, making the entire transaction worth $22,062. This insider now owns 12,500 shares in total.
Geron Corp (GERN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 61.30% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Here are Geron Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.27, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.02 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Geron Corp (NASDAQ: GERN) saw its 5-day average volume 15.09 million, a positive change from its year-to-date volume of 14.86 million. As of the previous 9 days, the stock’s Stochastic %D was 15.01%. Additionally, its Average True Range was 0.13.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 4.27%, which indicates a significant decrease from 16.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.77% in the past 14 days, which was lower than the 77.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2734, while its 200-day Moving Average is $3.7405. Nevertheless, the first resistance level for the watch stands at $1.6367 in the near term. At $1.6833, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.7367. If the price goes on to break the first support level at $1.5367, it is likely to go to the next support level at $1.4833. The third support level lies at $1.4367 if the price breaches the second support level.
Geron Corp (NASDAQ: GERN) Key Stats
With a market capitalization of 1.01 billion, the company has a total of 636,904K Shares Outstanding. Currently, annual sales are 76,990 K while annual income is -174,570 K. The company’s previous quarter sales were 47,540 K while its latest quarter income was -25,350 K.
